SIRT1 and interstitial lung disease: In addition, SIRT1 mRNA levels were found to be lower in circulating mononuclear cells of SSc patients with ILD in respect to those without pulmonary involvement, a downregulation that was found to be preferentially associated with the dcSSc subset and anti-topoisomerase I antibody (ATA) positivity [7].